First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Steven Kerr*, Mark Joy, Fatemeh Torabi, Stuart Bedston, Ashley Akbari, Utkarsh Agrawal, Jillian Beggs, Declan Bradley, Antony Chuter, Annemarie B. Docherty, David Ford, Richard Hobbs, Srinivasa Vittal Katikireddi, Emily Lowthian, Simon de Lusignan, Ronan Lyons, James Marple, Colin McCowan, Dylan McGagh, Jim McMenaminEmily Moore, Josephine L.K. Murray, Rhiannon K. Owen, Jiafeng Pan, Lewis Ritchie, Syed Ahmar Shah, Ting Shi, Sarah Stock, Ruby S.M. Tsang, Eleftheria Vasileiou, Mark Woolhouse, Colin R. Simpson, Chris Robertson, Aziz Sheikh

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)
14 Downloads (Pure)

Fingerprint

Dive into the research topics of 'First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales'. Together they form a unique fingerprint.

Medicine & Life Sciences